Market
What will be the outcome of the hostile takeover bid for Lykos Therapeutics by June 30, 2025?
3
Lykos Therapeutics•Antonio Gracias•Tesla•Gracias•Maps•Rick Doblin•Jeff Aronin•Paragon Biosciences•Lykos•FDA•Helena
Resolution / Starting Odds
Antonio Gracias acquires controlling stake • 25%
Helena vetoes the deal • 25%
Deal falls through for other reasons • 25%
Other outcome • 25%
Official announcements from Lykos Therapeutics or financial news outlets
Story
Antonio Gracias Leads Hostile Takeover Bid for MDMA Startup Lykos Therapeutics, Backed by $100 Million Funding and Rick Doblin
Jan 10, 2025, 05:38 AM
Lykos Therapeutics, a startup focused on MDMA-based therapies, is facing a hostile takeover bid led by Antonio Gracias, an early investor in Tesla. Gracias, who is allied with Maps founder Rick Doblin, aims to secure a controlling stake in the company with the support of Jeff Aronin, a prominent figure in the pharmaceutical industry and founder of Paragon Biosciences. The bid comes amid ongoing challenges for Lykos, including issues related to sexual abuse by therapists during clinical trials, which were highlighted during a recent FDA review. Additionally, Helena, which spearheaded Lykos's $100 million funding round last year, is reportedly seeking to sever ties between Lykos and the non-profit organization Maps, holding veto rights over any potential deal.
View original story
Similar markets
Delayed • 25%
Modified Terms • 25%
Cancelled • 25%
Completed • 25%
Other Outcome • 25%
Completed Sale • 25%
Talks Abandoned • 25%
Ongoing Negotiations • 25%
Rejected • 25%
Accepted • 25%
No decision • 25%
Counter-offer accepted • 25%
Acquisition Abandoned • 25%
Acquisition Completed • 25%
Other Outcomes • 25%
Acquisition Delayed • 25%
Yes • 50%
No • 50%
Offer rejected • 25%
Offer revised • 25%
Other outcome • 25%
Acquisition completed • 25%
Acquisition delayed • 25%
No official outcome by end of 2025 • 25%
Acquisition abandoned • 25%
Acquisition completed • 25%
Yes • 50%
No • 50%
No new investment • 25%
Additional Bitcoin purchase • 25%
New technology acquisition • 25%
Partnership with another tech firm • 25%
Acquisition not completed • 25%
Acquisition completed at a different price • 25%
Acquisition completed at proposed price • 25%
Acquisition rejected • 25%
Negotiations extended • 34%
Sale completed • 33%
Negotiations fail • 33%